Bovine spongiform encephalopathy | Epidermal growth factor receptor | recombinant | hormone | The Limits to Growth | Recombinant DNA | growth | Economic growth | population growth | Insulin-like growth factor 1 | growth hormone | Exponential growth | epidermal growth factor receptor | economic growth | African Growth and Opportunity Act | Vascular endothelial growth factor A | recombinant DNA | Recombinant | Population growth | Luteinizing hormone | growth rate | Growth hormone | General Growth Properties | First Growth | Fibroblast growth factor | Zero population growth | Vascular endothelial growth factor | vascular endothelial growth factor | Thyroid-stimulating hormone | The Elusive Quest for Growth |
In 1997, Wilson and Akre began work on a story regarding the agricultural biotechnology company Monsanto and recombinant bovine growth hormone (rBGH), a milk additive that had been approved for use by the Food and Drug Administration but also blamed for a number of health issues.